Cargando…
Enrichment and mutation detection of circulating tumor cells from blood samples
The potential of circulating tumor cells (CTCs) in the diagnosis and prognosis of cancer patients has become increasingly attractive. However, molecular analysis of CTCs is hindered by low sensitivity and a high level of background leukocytes in CTC enrichment technologies. We have developed a novel...
Autores principales: | Kou, Ruqin, Zhao, Jian, Gogoi, Priya, Carskadon, Shannon, Chow, Will, Hwang, Clara, Palanisamy, Nallasivam, Leung, Conrad, Wang, Yixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983925/ https://www.ncbi.nlm.nih.gov/pubmed/29620284 http://dx.doi.org/10.3892/or.2018.6342 |
Ejemplares similares
-
Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression
por: Goel, Sakshi, et al.
Publicado: (2021) -
Evaluation of Tissue PCA3 Expression in Prostate Cancer by RNA in situ Hybridization - A Correlative Study with Urine PCA3 and TMPRSS2-ERG
por: Warrick, Joshua I., et al.
Publicado: (2013) -
Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples
por: Gogoi, Priya, et al.
Publicado: (2016) -
The miR-124-Prolyl Hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression
por: Chakravarthi, Balabhadrapatruni V. S. K., et al.
Publicado: (2014) -
Novel Dual Color Immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma
por: Bhalla, Ritu, et al.
Publicado: (2013)